Materials and methods: response. They can be inserted in awake as during mechanical ventilation, hemodynamic well as anaesthetized patients with or without parameters before, during and after insertion using muscle relaxant. The I-Gel is a new, and postoperative complications in Supraglottic devices are useful advent in the single use, non-inflatable supraglottic airway anaesthetised patients undergoing elective airway management, filling a niche between for use in anaesthesia during spontaneous or surgical procedures. the facemask and tracheal tube in terms of intermittent positive pressure ventilation. The both the anatomical position and the degree of shape, softness and contours accurately mirror invasiveness. It is easy to insert them blindly the perilaryngeal framework itself and create in to the hypopharynx to form a seal around Sixty patients of either sex in the age group the perfect fit. As it has no inflatable cuff, it has the larynx and has an important role in the of 18-60 years were selected randomly. several potential advantages including easier management of difficult intubation and failed Patients were divided into two groups i n s e r t i o n , m i n i m a l r i s k o f t i s s u e intubation. Laryngoscopy and muscle comprising of thirty patients each and compression,stability after insertion and an relaxation are not necessary for the insertion comparison was made between LMA-C integrated gastric channel is provided for of supraglottic device. As it avoids invasion of Classic and I-Gel supraglottic device. In gastric suction for passage of nasogastric tube vocal cords, incidence of injury inside the oral group 1, I-gel and in group 2, LMA-C was to empty the stomach. The objective of our cavity and the occurrence of sore throat also inserted. The hemodynamic stability, ease of study was to compare two supraglottic decreases. These devices are better tolerated insertion, number of attempts & time devices, classic LMA and I-Gel for ease of than the tracheal tube at 'lighter' levels of required for inser tion and airway insertion, position within the airway, ease manipulation required for insertion were anaesthesia and have minimal cardiovascular

Inj. Hyperbaric Bupivacaine (0.5%) 17.5mg (3.5ml) + Preservative free Inj. Morphine Sulphate 100µg (0.1ml) intrathecaly to a total volume of 3.6ml Group B Inj. Hyperbaric Bupivacaine (0.5%) 17.5mg (3.5ml) + Inj. Normal saline (0.9%) 0.1ml intrathecaly to a total volume of 3.6ml